--- title: "Legend Biotech CEO Ingrid Zhang files initial beneficial ownership statement" type: "News" locale: "en" url: "https://longbridge.com/en/news/299230177.md" description: "Legend Biotech filed an initial SEC Form 3 on September 15, reporting that CEO Ingrid Zhang has acquired beneficial ownership of the company's stock. The disclosure was published via EDGAR on September 16, 2026." datetime: "2026-09-16T20:17:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/299230177.md) - [en](https://longbridge.com/en/news/299230177.md) - [zh-HK](https://longbridge.com/zh-HK/news/299230177.md) generator: "portal-rs" --- # Legend Biotech CEO Ingrid Zhang files initial beneficial ownership statement - Legend Biotech named Ingrid Zhang as chief executive officer in an initial SEC Form 3 filing dated Sept. 15. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001964342-26-000003), on September 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here ### Related Stocks - [LEGN.US](https://longbridge.com/en/quote/LEGN.US.md) ## Related News & Research - [How ASH Abstract Acceptances Will Impact Legend Biotech Stock (LEGN)](https://longbridge.com/en/news/304646665.md) - [Legend Biotech's LB2501 Shows 100% Complete Response Rate in Eight Patients at Dose Level 2](https://longbridge.com/en/news/304290227.md) - [Legend Biotech to Present Cell-Therapy Data at ASH 2026](https://longbridge.com/en/news/304362764.md) - [Prediction: Nebius Stock Will Surge 95% in a Year, According to Wall Street. Should You Buy It Before Nov. 12?](https://longbridge.com/en/news/304627115.md) - [What Is Drawing Attention To Legend Biotech (LEGN)?](https://longbridge.com/en/news/302964375.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**